NM_145038.5:c.1418C>T
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_145038.5(DRC1):c.1418C>T(p.Ala473Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000237 in 1,614,200 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A473D) has been classified as Uncertain significance.
Frequency
Consequence
NM_145038.5 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 21Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- spermatogenic failure 80Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DRC1 | ENST00000288710.7 | c.1418C>T | p.Ala473Val | missense_variant | Exon 11 of 17 | 2 | NM_145038.5 | ENSP00000288710.2 | ||
| DRC1 | ENST00000439066.2 | n.148C>T | non_coding_transcript_exon_variant | Exon 2 of 5 | 3 | |||||
| DRC1 | ENST00000649059.1 | n.*381C>T | non_coding_transcript_exon_variant | Exon 10 of 16 | ENSP00000497543.1 | |||||
| DRC1 | ENST00000649059.1 | n.*381C>T | 3_prime_UTR_variant | Exon 10 of 16 | ENSP00000497543.1 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152214Hom.: 1 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000290 AC: 73AN: 251452 AF XY: 0.000294 show subpopulations
GnomAD4 exome AF: 0.000226 AC: 331AN: 1461868Hom.: 1 Cov.: 33 AF XY: 0.000239 AC XY: 174AN XY: 727228 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000341 AC: 52AN: 152332Hom.: 1 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74496 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
The A473V variant in the DRC1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The A473V variant is observed in 29/66,340 (0.043%) alleles from individuals of European (non-Finnish) background in the ExAC dataset (Lek et al., 2016). The A473V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved, and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret A473V as a variant of uncertain significance.
Inborn genetic diseases Uncertain:1
The c.1418C>T (p.A473V) alteration is located in exon 11 (coding exon 11) of the DRC1 gene. This alteration results from a C to T substitution at nucleotide position 1418, causing the alanine (A) at amino acid position 473 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Primary ciliary dyskinesia Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 473 of the DRC1 protein (p.Ala473Val). This variant is present in population databases (rs199574440, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with DRC1-related conditions. ClinVar contains an entry for this variant (Variation ID: 407102). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Primary ciliary dyskinesia 21 Uncertain:1
DRC1-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at